Page last updated: 2024-11-08

desoxycorticosterone acetate and Thrombotic Microangiopathies

desoxycorticosterone acetate has been researched along with Thrombotic Microangiopathies in 1 studies

Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.

Thrombotic Microangiopathies: Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwazu, Y1
Muto, S1
Ioka, T1
Watanabe, Y1
Iwazu, K1
Kusano, E1
Nagata, D1

Other Studies

1 other study available for desoxycorticosterone acetate and Thrombotic Microangiopathies

ArticleYear
Multiple Sclerosis Drug Fingolimod Induces Thrombotic Microangiopathy in Deoxycorticosterone Acetate/Salt Hypertension.
    Hypertension (Dallas, Tex. : 1979), 2018, Volume: 72, Issue:3

    Topics: Animals; Arterioles; Blood Pressure; Desoxycorticosterone Acetate; Endothelium, Vascular; Fingolimod

2018